347 related articles for article (PubMed ID: 26039049)
41. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B
Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611
[TBL] [Abstract][Full Text] [Related]
42. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data.
Porembka MR; Abraham RL; Sefko JA; Deshpande AD; Jeffe DB; Margenthaler JA
Ann Surg Oncol; 2008 Oct; 15(10):2709-19. PubMed ID: 18483831
[TBL] [Abstract][Full Text] [Related]
43. Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI.
Vicini F; Shah C; Ben Wilkinson J; Keisch M; Beitsch P; Lyden M
Ann Surg Oncol; 2013 Apr; 20(4):1275-81. PubMed ID: 23054123
[TBL] [Abstract][Full Text] [Related]
44. Surgery and adjuvant radiotherapy for unilateral ductal carcinoma in situ (DCIS) in women aged over 70 years: A population based cohort study.
Jauhari Y; Gannon MR; Tsang C; Horgan K; Dodwell D; Clements K; Medina J; Tang S; Pettengell R; Cromwell DA
Eur J Surg Oncol; 2019 Aug; 45(8):1378-1387. PubMed ID: 30878169
[TBL] [Abstract][Full Text] [Related]
45. Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?
Byng D; Retèl VP; Schaapveld M; Wesseling J; van Harten WH;
Breast Cancer Res Treat; 2021 May; 187(1):187-196. PubMed ID: 33389397
[TBL] [Abstract][Full Text] [Related]
46. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.
de Mascarel I; MacGrogan G; Mathoulin-Pélissier S; Soubeyran I; Picot V; Coindre JM
Cancer; 2002 Apr; 94(8):2134-42. PubMed ID: 12001109
[TBL] [Abstract][Full Text] [Related]
47. A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Rakovitch E; Nofech-Mozes S; Hanna W; Baehner FL; Saskin R; Butler SM; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Robertson SJ; Slodkowska E; Fong C; Anderson JM; Jamshidian F; Miller DP; Cherbavaz DB; Shak S; Paszat L
Breast Cancer Res Treat; 2015 Jul; 152(2):389-98. PubMed ID: 26119102
[TBL] [Abstract][Full Text] [Related]
48. Is there a low-grade precursor pathway in breast cancer?
King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
[TBL] [Abstract][Full Text] [Related]
49. Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Elshof LE; Tryfonidis K; Slaets L; van Leeuwen-Stok AE; Skinner VP; Dif N; Pijnappel RM; Bijker N; Rutgers EJ; Wesseling J
Eur J Cancer; 2015 Aug; 51(12):1497-510. PubMed ID: 26025767
[TBL] [Abstract][Full Text] [Related]
50. Predictors of local recurrence in a population-based cohort of women with ductal carcinoma in situ treated with breast conserving surgery alone.
Wai ES; Lesperance ML; Alexander CS; Truong PT; Moccia P; Culp M; Lindquist J; Olivotto IA
Ann Surg Oncol; 2011 Jan; 18(1):119-24. PubMed ID: 20645008
[TBL] [Abstract][Full Text] [Related]
51. Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion.
Li C; Yang Y; Wang J; Jin K; Yang Z; Yu X; Guo X; Chen X
Cancer Med; 2021 Oct; 10(20):7203-7212. PubMed ID: 34547183
[TBL] [Abstract][Full Text] [Related]
52. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
[TBL] [Abstract][Full Text] [Related]
53. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
[TBL] [Abstract][Full Text] [Related]
54. Ductal carcinoma in situ: trends in treatment over time in the US.
Zujewski JA; Harlan LC; Morrell DM; Stevens JL
Breast Cancer Res Treat; 2011 May; 127(1):251-7. PubMed ID: 20931276
[TBL] [Abstract][Full Text] [Related]
55. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975
[TBL] [Abstract][Full Text] [Related]
56. The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast.
Barnes NL; Dimopoulos N; Williams KE; Howe M; Bundred NJ
Eur J Surg Oncol; 2014 Mar; 40(3):249-54. PubMed ID: 24433818
[TBL] [Abstract][Full Text] [Related]
57. DCIS treated with excision alone using the National Comprehensive Cancer Network (NCCN) guidelines.
Wehner P; Lagios MD; Silverstein MJ
Ann Surg Oncol; 2013 Oct; 20(10):3175-9. PubMed ID: 23975306
[TBL] [Abstract][Full Text] [Related]
58. The use of oncoplastic reduction techniques to reconstruct partial mastectomy defects in women with ductal carcinoma in situ.
Song HM; Styblo TM; Carlson GW; Losken A
Breast J; 2010; 16(2):141-6. PubMed ID: 20102367
[TBL] [Abstract][Full Text] [Related]
59. Modern Trends in the Surgical Management of Paget's Disease.
Wong SM; Freedman RA; Stamell E; Sagara Y; Brock JE; Desantis SD; Golshan M
Ann Surg Oncol; 2015 Oct; 22(10):3308-16. PubMed ID: 26202552
[TBL] [Abstract][Full Text] [Related]
60. A comparison of two models for breast cancer mortality for women with ductal carcinoma in situ: an SEER-based analysis.
Giannakeas V; Sopik V; Narod SA
Breast Cancer Res Treat; 2018 Jun; 169(3):587-594. PubMed ID: 29445939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
